Disease-modifying drugs (DMARDs), Psoriatic arthritis, Real-world evidence

被引：1
|
作者：
Song, J. [1 ,2 ]
Abe, C. [1 ,2 ]
Banefelt, J. [3 ]
Rieem-Dun, A. [3 ]
Willems, D. [1 ]
Morup, M. [1 ]
Taieb, V. [1 ]
Lindberg, I. [1 ]
Welby, S. [1 ]
机构：
[1] UCB Pharma, Braine Lalleud, Belgium
[2] Karolinska Inst, Stockholm, Sweden
[3] Quantify Res, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Disease-modifying drugs (DMARDs); Psoriatic arthritis; Real-world evidence;
D O I：
10.1136/annrheumdis-2023-eular.3573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1785 / 1786
页数：2
相关论文
共 50 条
  • [41] THE HEALTH AND ECONOMIC CONSEQUENCES OF DELAY IN STARTING DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID ARTHRITIS
    Van Doornum, S.
    Roberts, L.
    Reed, M. D.
    Liew, D.
    VALUE IN HEALTH, 2012, 15 (07) : A448 - A448
  • [42] THE HEALTH AND ECONOMIC CONSEQUENCES OF DELAY IN STARTING DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) IN RHEUMATOID ARTHRITIS
    Van Doornum, S.
    Franklyn, K.
    Tacey, M.
    Roberts, C.
    Liew, D.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 2 - 2
  • [43] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [44] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
    Khoshroo, Ahmadreza
    Ramezani, Keyvan
    Moghimi, Niusha
    Bonakdar, Moein
    Ramezani, Nazanin
    INFLAMMOPHARMACOLOGY, 2023, 31 (02) : 689 - 697
  • [45] The effect of disease-modifying antirheumatic drugs (DMARDs) on bone homeostasis in rheumatoid arthritis (RA) patients
    Ahmadreza Khoshroo
    Keyvan Ramezani
    Niusha Moghimi
    Moein Bonakdar
    Nazanin Ramezani
    Inflammopharmacology, 2023, 31 : 689 - 697
  • [46] Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease-Modifying Antirheumatic Drugs: Results From a Real-World Study
    Alemao, Evo B.
    Bao, Ying
    Weinblatt, Michael E.
    Shadick, Nancy
    ARTHRITIS CARE & RESEARCH, 2020, 72 (02) : 176 - 183
  • [47] Impact of adherence to disease-modifying drugs in multiple sclerosis: A study on Italian real-world data
    Belotti, Laura Maria Beatrice
    Di Martino, Mirko
    Zenesini, Corrado
    Vignatelli, Luca
    Baldin, Elisa
    Baccari, Flavia
    Ridley, Ben
    Nonino, Francesco
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 80
  • [48] Effectiveness of biologics and disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: Real-world outcomes from the RADIUS observational registry
    Weaver, A
    Lautzenheiser, RL
    Schiff, MH
    Gibofsky, A
    Perruquet, JL
    Luetkemeyer, J
    Paulus, HE
    Xia, HA
    Leff, JA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S721 - S721
  • [49] Combination of methotrexate with oral disease-modifying antirheumatic drugs in psoriatic arthritis: a systematic review
    Hsieh, Tyng-Shiuan
    Tsai, Tsen-Fang
    IMMUNOTHERAPY, 2024, 16 (02) : 115 - 130
  • [50] Predictors of effectiveness of biologic disease-modifying antirheumatic drugs (bDMARD) in the treatment of psoriatic arthritis
    Brandao, Natalia Dias
    Morgado, Marina
    Oliveira, Gerusa A.
    Acurcio, Francisco de Assis
    Guerra Junior, Augusto Afonso
    Alvares-Teodoro, Juliana
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 170 - 171
12345